Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023)

Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023)

Background: Thromboembolic disease is associated with a high rate of disability or death and gravely jeopardizes people’s health and places considerable financial pressure on society. The primary treatment for thromboembolic illness is anticoagulant medication. Fondaparinux, a parenteral anticoagula...

Full description

Bibliographic Details
Main Authors: Qinan Yin, Lizhu Han, Yin Wang, Fengjiao Kang, Fengqun Cai, Liuyun Wu, Xingyue Zheng, Lian Li, Li e Dong, Limei Dong, Shuhong Liang, Min Chen, Yong Yang, Yuan Bian
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Pharmacology
Subjects:
fondaparinux
clinical practice guideline
thromboembolic disease
clinical rational use of drugs
pharmaceutical practice
treatments
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1352982/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1352982/full

Similar Items